ARTICLE | Company News
Bayer reorganizes R&D
November 30, 2017 11:34 PM UTC
Bayer AG (Xetra:BAYN) said Thursday it will consolidate its R&D into one unit led by Jörg Möller. Möller, the head of development of the company’s pharmaceutical division, will become head of R&D, effective Jan. 1...